Tezkor likvidlik: Inhibikase Therapeutics Inc (IKT)

inhibikase.com (IKT) grafik logotipi

Inhibikase Therapeutics (IKT) c-Abl proteinini bloklash orqali Parkinson kasalligida miya degradatsiyasining oldini oluvchi davolash vositalarini ishlab chiqadi. Biznesning yuqori masshtablanuvchanligi patent himoyasi va past ishlab chiqarish xarajatlari bilan birga terapiyaning yuqori narxi hisobiga ta'minlanadi. Joriy ko'rsatkich 15.14 darajasida turibdi. Ushbu narxlar grafigi global logistika markazlari orqali biomateriallar tashilishining qat'iy nazorati bo'yicha ma'lumotlarni to'ldiradi.

Inhibikase Therapeutics Inc (IKT) - Oraliq qoplash koeffitsiyenti 04.07.2022dan 31.10.2026gacha

inhibikase.com (IKT) moliyaviy va bozor koʻrsatkichlari kesimi

- aksiya kursi va ekspertlarning narx prognozi:
Aksiya narxi Inhibikase|IKT - Tahlilchilar median maqsadi
- kompaniyaning birjadagi kapitallashuv ko'rsatkichlari:
Bozor qiymati Inhibikase|IKT - Biznes qiymati
- balans kapitallashuvi bo'yicha ma'lumotlar:
Bitta aksiya hisobiga balans qiymati Inhibikase Therapeutics|IKT - Kompaniyaning buxgalteriya qiymati|Bozor kapitallashuvining balans qiymatiga nisbati inhibikase.com|IKT - Kompaniya aktivlarining umumiy hajmi
- qarzlar va to'lov qobiliyati haqida ma'lumot:
Umumiy qarzning kapitalga nisbati Inhibikase Therapeutics|IKT - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzning kapitalga nisbati Inhibikase Therapeutics, Inc.|IKT - Kompaniyaning umumiy qarz majburiyatlari|Qarzning balans kapitallashuviga nisbati Inhibikase|IKT - Kompaniyaning uzoq muddatli qarzlari|Kompaniyaning qisqa muddatli qarzlari Inhibikase Therapeutics|Tezkor likvidlik inhibikase.com
- foyda va baholash multiplikatorlari ko'rsatkichlari:
IKT - Sof moliyaviy natija
Kompaniyaning barcha koʻrsatkichlari tahlili:Inhibikase Therapeutics
inhibikase.com yetakchi tovari

Investorlar Inhibikase Therapeutics (IKT) kompaniyasining favqulodda kapital jalb qilmasdan turib ishlanmalarni moliyalashtirish qobiliyati orqali uning barqarorligini baholamoqdalar. Ushbu ko'rsatkich illikvid zaxiralarni butunlay istisno qilgan holda, faqat naqd pul va debitorlik qarzlari yordamida qisqa muddatli majburiyatlarning qoplash koeffitsiyentini o'lchaydi. Tezkor likvidlikning oyma-oy dinamikasi neyrodegenerativ kasalliklar uchun dori vositalarini ishlab chiqish davridagi naqd pul taqchilligi risklarini kuzatish imkonini beradi. Ushbu ko'rsatkichning yuqori darajasi moliyaviy avtonomiyani va defoltga qarshi himoyani tasdiqlaydi.

Raqobatchilar tahlili

BIIB: Tezkor likvidlik koeffitsiyenti|NBIX - Oraliq qoplama koeffitsiyenti|Tezkor likvidlik Regencell Bioscience|Shoshilinch likvidlik koeffitsiyenti AXSM (axsome.com)|Tezkor likvidlik koeffitsiyenti ACAD|XENE (Xenon Pharmaceuticals Inc.) - Oraliq qoplash koeffitsiyenti|Tezkor likvidlik koeffitsiyenti VKTX (Viking Pharma)|Oraliq qoplama koeffitsiyenti Supernus Corp (SUPN)|Catalyst Pharmaceuticals - Tezkor likvidlik koeffitsiyenti|DNLI: Tezkor likvidlik|HRMY: Tezkor likvidlik koeffitsiyenti|BHVN - Oraliq qoplama koeffitsiyenti|Tezkor likvidlik Amylyx|Tezkor likvidlik koeffitsiyenti Trevi Corp|Tezkor likvidlik koeffitsiyenti PRAX|Tezkor likvidlik koeffitsiyenti anavex.com (AVXL)|Tezkor likvidlik CeriBell CBLL|Oraliq qoplama koeffitsiyenti Prothena Corp (PRTA)|Alector Therapeutics - Tezkor likvidlik koeffitsiyenti|Shoshilinch likvidlik Annexon Biosciences Inc.|OMER (omeros.com) - Tezkor likvidlik ko‘rsatkichi|neurogene.com - Oraliq qoplash koeffitsiyenti|Tezkor likvidlik ko‘rsatkichi ACIU|VYGR (Voyager Therapeutics Inc) - Oraliq likvidlik koeffitsiyenti|Tezkor likvidlik koeffitsiyenti NMRA|SCLX (Scilex Holding Company, Inc.) - Oraliq qoplash koeffitsiyenti|Tezkor likvidlik koeffitsiyenti TVGN (Tevogen Bio Holdings)|Alpha Cognition Inc (ACOG) - Shoshilinch likvidlik|CGTX - Tezkor likvidlik|Oraliq qoplash koeffitsiyenti SAVA (Cassava Sciences Inc)|ASRT: Tezkor likvidlik koeffitsiyenti|Coya Therapeutics (COYA) - Tezkor likvidlik koeffitsiyenti|Tezkor likvidlik VistaGen Therapeutics, Inc.|Ovid Rx - Kritik likvidlik koeffitsiyenti|Tezkor likvidlik koeffitsiyenti ABOS|CRVO - Shoshilinch likvidlik|Alterity Therapeutics Limited - Tezkor likvidlik ko‘rsatkichi|Tezkor likvidlik koeffitsiyenti Clene Inc CLNN|PEPG: Tezkor likvidlik ko‘rsatkichi|Jupiter Neurosciences, Inc. - Oraliq likvidlik koeffitsiyenti|RLMD: Tezkor likvidlik koeffitsiyenti|ANVS - Oraliq qoplama koeffitsiyenti|GRCE (Grace Therapeutics Inc) - Tezkor likvidlik koeffitsiyenti|Tezkor likvidlik ko‘rsatkichi Firefly Neuro (AIFF)|Tezkor likvidlik Klotho Neurosciences Inc (KLTO)|Oraliq qoplama koeffitsiyenti neurosense-tx.com|Tezkor likvidlik koeffitsiyenti RVPH (Reviva Pharmaceuticals Holdings, Inc.)|Oraliq qoplama koeffitsiyenti MetaVia Inc. (MTVA)|NRXS - Tezkor likvidlik|HSDT - Tezkor likvidlik koeffitsiyenti|PASG (passagebio.com) - Tezkor likvidlik ko‘rsatkichi|NEUP: Oraliq likvidlik koeffitsiyenti|Tezkor likvidlik Minerva Neurosciences, Inc.|Shoshilinch likvidlik koeffitsiyenti ATHA (Athira Pharma Inc)|Tezkor likvidlik koeffitsiyenti ADXN|ALZN - Shoshilinch likvidlik|Cyclerion Therapeutics, Inc. - Tezkor likvidlik ko‘rsatkichi|Tezkor likvidlik koeffitsiyenti Protagenic Therapeutics Inc. PTIX|KTTA - Tezkor likvidlik|Oraliq qoplash koeffitsiyenti CRGT (Cortigent, Inc.)|Avenue Therapeutics, Inc (ATXI) - Tezkor likvidlik|Shoshilinch likvidlik BrainStorm Cell Therapeutics Inc. (BCLI)|CARA (Cara Therapeutics, Inc.) - Tezkor likvidlik koeffitsiyenti|chromocell.com (CHRO) - Oraliq qoplama koeffitsiyenti|Tezkor likvidlik Eliem Therapeutics (ELYM)|intracellulartherapies.com - Shoshilinch likvidlik koeffitsiyenti|Tezkor likvidlik koeffitsiyenti LBPH (Longboard Pharma)|Oraliq qoplash koeffitsiyenti MRNS|NKGen Biotech, Inc. - Tezkor likvidlik koeffitsiyenti|Oraliq qoplama koeffitsiyenti neurobopharma.com NRBO|SAGE: Tezkor likvidlik koeffitsiyenti|SNPX (Synaptogenix Inc.) - Tezkor likvidlik|TRVN (Trevena, Inc) - Tezkor likvidlik koeffitsiyenti|Vigil Neuro (VIGL) - Oraliq qoplama koeffitsiyenti|Tezkor likvidlik Anew Medical (WENA)|Tezkor likvidlik koeffitsiyenti cerevel.com (CERE)